Pfizer’s Q4 net profit rises 3% to Rs 130 crore on higher income


Pfizer, a global pharmaceutical enterprise, pronounced a marginal boom in its net income for the fourth area of monetary yr 2023 on Monday. The employer’s net earnings rose by using three% to Rs a hundred thirty crore in Q4 FY23, from Rs 126 crore in Q4 FY22. The employer said in a regulatory submitting that its general profits additionally grew through 6.5% to Rs 604 crore in Q4 FY23, from Rs 567 crore in Q4 FY22.

The agency’s profits consistent with percentage (EPS) stood at Rs eleven.65 in Q4 FY23, as compared to Rs eleven.28 in Q4 FY22. The enterprise’s board of administrators encouraged a dividend of Rs 25 in keeping with fairness percentage for FY23. For the full year ended March 31, 2023, the employer posted a internet income of Rs 624 crore, up 1.8% from Rs 613 crore in FY22. The employer’s general earnings multiplied by means of 9.2% to Rs 2,540 crore in FY23, from Rs 2,326 crore in FY22.